Cadila Healthcare had hit a new high yesterday at Rs.439.80 and today, it hit another new high at Rs.460, with an over 4.5 times surge in volumes.

There is very good news coming from the company. It announced yesterday that the US FDA had inspected its Moraiya plant and stated that the plant met all its manufacturing norms.

In the Press Release issued, the company said, “United States Food and Drug Administration (USFDA) inspected company's Moraiya facility from February 6, 2017 to February 15, 2017. At the end of the inspection no observation (483) is issued." 

Any good news from the US FDA for the Indian markets is reason for celebration as pharma companies have been inundated with only negative observations from the FDA.